Back to Products

Mounjaro (Tirzepatide)

FDA APPROVED
PRESCRIPTIONfat lossmetabolism

A GLP-1/GIP dual agonist medication for weight loss and blood sugar control.

How It Works

Mimics natural gut hormones (GLP-1 and GIP) that signal fullness, slow stomach emptying, and increase insulin sensitivity.

Benefits

  • ✓Significant weight loss
  • ✓Improved blood sugar control
  • ✓Appetite suppression
  • ✓Better metabolic health
  • ✓Cardiovascular benefits

Potential Side Effects

  • ⚠Nausea (common initially)
  • ⚠Fatigue
  • ⚠Gastrointestinal issues
  • ⚠Potential gallbladder problems

FDA Status

FDA-approved for type 2 diabetes and weight management

Clinical Evidence

Extensive randomized controlled trials showing 15-20% body weight reduction. Strong safety and efficacy data.

Common Dosage

5-15mg weekly injection

⚠ Always consult with a healthcare professional before starting any new supplement or treatment.

Related Products

5-Amino-1MQ

A peptide that inhibits NNMT enzyme to increase cellular metabolism.

Related News & Research

GLP-1 Agonists Continue to Transform Weight Loss Treatment in 2025

Jan 10, 2025

New data shows dual GLP-1/GIP agonists like Tirzepatide achieving unprecedented weight loss results with improved patient compliance.

Medical Disclaimer

The information provided on this page is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any new treatment, supplement, or making changes to your health regimen.